# Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of Adenomyosis

> **NCT06174792** · — · UNKNOWN · sponsor: **University of Palermo** · enrollment: 40 (estimated)

## Conditions studied

- Adenomyosis

## Interventions

- **DRUG:** Drospirenone 4 MG

## Key facts

- **NCT ID:** NCT06174792
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-30
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06174792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06174792, "Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of Adenomyosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06174792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*